Skip to main content

DEL in action – selected case studies

How leading pharmaceutical and biotech partners are accelerating early drug discovery with Vipergen’s DEL technology and integrated screening platform.

Some numbers

1.5B+

Compounds synthesized

12/20

Top global pharma partners

120+

Completed screening projects

+20 yrs

DEL expertise since 2005